TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Scanfarma AB
Closing information (x1000 SEK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
9,980
|
10,382
|
11,664 |
| Financial expenses |
6
|
1
|
1 |
| Earnings before taxes |
750
|
558
|
-181 |
| EBITDA |
719
|
556
|
-180 |
| Total assets |
7,515
|
8,000
|
7,535 |
| Current assets |
7,260
|
8,000
|
7,535 |
| Current liabilities |
879
|
1,457
|
1,427 |
| Equity capital |
4,605
|
4,128
|
3,673 |
| - share capital |
100
|
100
|
100 |
| Employees (average) |
5
|
6
|
7 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
61.3%
|
51.6%
|
48.7% |
| Turnover per employee |
1,996
|
1,730
|
1,666 |
| Profit as a percentage of turnover |
7.5%
|
5.4%
|
-1.6% |
| Return on assets (ROA) |
10.1%
|
7.0%
|
-2.4% |
| Current ratio |
825.9%
|
549.1%
|
528.0% |
| Return on equity (ROE) |
16.3%
|
13.5%
|
-4.9% |
| Change turnover |
-402
|
-1,282
|
-466 |
| Change turnover % |
-4%
|
-11%
|
-4% |
| Chg. No. of employees |
-1
|
-1
|
-1 |
| Chg. No. of employees % |
-17%
|
-14%
|
-13% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.